<?xml version="1.0" encoding="UTF-8"?>
<funding-group>
 <award-group id="award001">
  <funding-source>
   <institution>University of North Carolina at Chapel Hill School of Medicine</institution>
  </funding-source>
  <award-id>ECBR_003</award-id>
  <principal-award-recipient>
   <name>
    <surname>Stringer</surname>
    <given-names>Elizabeth</given-names>
   </name>
  </principal-award-recipient>
 </award-group>
 <funding-statement>This work was supported by the following funding sources: 1. Understanding Maternal Fetal Transmission of Zika virus ECBR_003 6/2016-6/2017 UNC Pilot to PI E. Stringer for startup supplies and recruitment of pregnancy cohort in Nicaragua 2. F Bucardo received a Fogarty fellowship from UNC that supported some of his effort on this work 3. Structure based design of recombinant Zika virus antigens for serodiagnosis R21 AI134073 (MPI: de Silva) NIH/NIAID 4. 00HVCLJB-2017-04191 (PI: de Silva) CDC Diagnosis of recent and remote Zika infections supported assay development and serologic testing of cohort specimens at UNC 5. NIH P01 AI106695 (EH); funders played no role in the writing of the manuscript or the decision to submit it for publication. 6. S. Becker-Dreps was supported by NIAID 5R21AI129532-02. 7. MHC is supported by NIH 1K22AI137306-01 and Thrasher Research Fund.</funding-statement>
</funding-group>
